Document:

Series G Unit Subscription Agreement, dated as of February 24, 2012

 Exhibit 10.2 
 Execution Version 
 SERIES G UNIT SUBSCRIPTION AGREEMENT

 THIS SERIES G UNIT SUBSCRIPTION AGREEMENT (this “Agreement”) is entered into on February 24,
2012, by and between LIGHTING SCIENCE GROUP CORPORATION, a Delaware corporation (the “Company”) and Mr. Leon Wagner (“Purchaser”). Defined terms used and not defined herein shall have the meanings
ascribed thereto in the Certificate of Designation (as defined below). 
 WHEREAS, the Company desires to sell to Purchaser and
Purchaser desires to buy from the Company 2,000 units (the “Series G Units”) of the Company’s securities at a purchase price of $1,000 per Series G Unit, with each Series G Unit consisting of: (a) one share of the
Company’s Series G Preferred Stock, par value $0.001 per share (“Series G Preferred Stock”); and (b) 83 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”)
on the terms and conditions set forth herein; 
 NOW, THEREFORE, in consideration of the mutual agreements herein
contained, the parties hereto agree as follows: 
 1. Purchase and Sale of Series G Units. On the date hereof, Purchaser
hereby agrees to purchase from the Company, and the Company agrees to sell to Purchaser, 2,000 Series G Units for aggregate consideration of $2,000,000.00 (the “Consideration”). 

2. Payment for Series G Units; Delivery of Certificate. On or prior to the date hereof, Purchaser shall transmit, or cause to be
transmitted, by wire transfer of immediately available funds to the Company, in accordance with the wire transfer instructions previously delivered to Purchaser, an amount equal to the Consideration. On or promptly following the date hereof, the
Company shall deliver to Purchaser, in accordance with this Agreement, certificates representing the shares of Series G Preferred Stock and shares of Common Stock of which the Series G Units are comprised. 

3. Opinion of Counsel. On the date hereof, Haynes and Boone, LLP, counsel for the Company, shall have delivered to Purchaser a
usual and customary opinion, substantially in the form attached hereto as Exhibit A, with respect to the issuance of the Series G Units purchased hereby. 
 4. Company Representations and Warranties. The Company represents and warrants to Purchaser that as of the date hereof: 

(a) The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of
Delaware and has the requisite corporate power to own its properties and carry on its business as presently conducted. 
 (b) The issuance, sale and delivery of the Series G Units in accordance with this Agreement have been duly authorized by all necessary corporate action on the part of the Company. 

 (c) This Agreement constitutes the legal, valid and binding obligation of
the Company, enforceable in accordance with its terms, and the execution, delivery and performance of this Agreement by the Company does not and will not conflict with, violate or cause a breach of any agreement, contract or instrument to which the
Company is a party or any judgment, order or decree to which the Company is subject. 
 (d) After giving pro
forma effect to the transactions contemplated hereby, Schedule 4(d) attached hereto sets forth, as of the close of business on the business day immediately preceding the date hereof, a true, complete and correct listing of all the
Company’s outstanding: (i) shares of Common Stock and (ii) securities convertible into or exchangeable for shares of Common Stock (the “Derivative Securities”), including the applicable exercise price of such
Derivative Securities, other than any Derivative Securities issued pursuant to the Company’s Amended and Restated Equity-Based Compensation Plan or the Company’s 2011 Employee Stock Purchase Plan (the “Management
Equity”). Except as set forth in Schedule 4(d) and except for any Management Equity, the Company has no other outstanding equity securities. 
 (e) SEC Reports; Financial Statements 
  

	 	i.	As of its filing date, the Form 10-K/A filed by the Company with the Securities and Exchange Commission (the “SEC”) on June 29, 2011, the
Form 10-Q filed by the Company with the SEC on May 16, 2011, the Form 10-Q filed by the Company with the SEC on August 15, 2011 and the Form 10-Q filed by the Company with the SEC on November 14, 2011 (collectively, the
“Company SEC Documents”), complied in all material respects with the applicable requirements of the Securities Act of 1933, as amended (the “1933 Act”), the Securities Exchange Act of 1934, as amended
(the “1934 Act”), and the Sarbanes-Oxley Act of 2002, as the case may be, including, in each case, the rules and regulations promulgated thereunder. 

 

	 	ii.	Except to the extent that information contained in the Company SEC Documents has been revised or superseded by a document the Company subsequently filed with the SEC,
the Company SEC Documents do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were
made, not misleading. 

  

	 	iii.	 The financial statements (including the related notes thereto) included in the Company SEC Documents comply as to form in all material respects with
applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) (except, in the
case of unaudited statements, as permitted by Form 10-Q of the SEC) applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and fairly present in all material respects the consolidated financial
position of the Company and its subsidiaries as of the dates thereof and their respective 

  
 - 2 -

	 	
consolidated results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal and recurring year-end audit adjustments that were not, or
are not expected to be, material in amount), all in accordance with GAAP and the applicable rules and regulations promulgated by the SEC. Since November 14, 2011, the Company has not made any change in the accounting practices or policies
applied in the preparation of its financial statements, except as required by GAAP, the rules of the SEC or policy or applicable law. 

  

	 	iv.	Since November 14, 2011, there has been no material and adverse change or development, or event involving such a prospective change, in the condition, business,
properties or results of operations of the Company and its subsidiaries. 

  

	 	(f)	The offer and sale of the Series G Units by the Company to Purchaser in the manner contemplated by this Agreement will be exempt from the registration requirements of
the 1933 Act. 

  

	 	(g)	The Company has complied in all material respects with the covenants set forth in (i) that certain Loan Security Agreement, dated as of November 22, 2010, by
and among the Company, the guarantors and lenders from time to time party thereto, Wells Fargo Bank, National Association, as agent, and Wells Fargo Capital Finance, LLC, as sole lead arranger, manager and bookrunner (the “Credit
Facility”), including without limitation Section 4 thereof, and (ii) that certain Second Lien Letter of Credit, Loan and Security Agreement, dated September 20, 2011, by and among the Company, as borrower, the guarantors
and lenders party from time to time thereto and Ares Capital Corporation, as agent (the “LC Facility” and together with the Credit Facility, the “Debt Facilities”). Immediately following the
consummation of the transactions contemplated hereby, the Company will be in compliance in all material respects with the covenants set forth in the Debt Facilities. Immediately following the repayment of any Consideration as required under
Section 9.7(b)(iii)(D) of the Credit Facility, the Company will be able to redraw amounts equal to at least such Consideration. 

 5. Purchaser Representations and Warranties. Purchaser represents and warrants to the Company that as of the date hereof: 

(a) Purchaser has the full power and authority to execute and deliver this Agreement and to perform all of its obligations
hereunder and thereunder, and to purchase, acquire and accept delivery of the Series G Units. 
 (b) The Series G
Units are being acquired for Purchaser’s own account and not with a view to, or intention of, distribution thereof in violation of the 1933 Act, or any applicable state securities laws. 

  
 - 3 -

 (c) Purchaser will not make any sale, transfer or other disposition of the
Series G Units in violation of the 1933 Act, the 1934 Act, as amended, the rules and regulations promulgated thereunder or any applicable state securities laws. 
 (d) Purchaser is sophisticated in financial matters and is able to evaluate the risks and benefits of an investment in the Series G Units. Purchaser understands and acknowledges that such investment is a
speculative venture, involves a high degree of risk and is subject to complete risk of loss. Purchaser has carefully considered and has, to the extent Purchaser deems necessary, discussed with Purchaser’s professional legal, tax, accounting and
financial advisers the suitability of its investment in the Series G Units. 
 (e) Purchaser is able to bear the
economic risk of its investment in its Series G Units for an indefinite period of time because the Series G Units have not been registered under the 1933 Act and, therefore, cannot be sold unless subsequently registered under the 1933 Act or an
exemption from such registration is available. Purchaser: (i) understands and acknowledges that the Series G Units being issued to Purchaser have not been registered under the 1933 Act, nor under the securities laws of any state, nor under the
laws of any other country and (ii) recognizes that no public agency has passed upon the accuracy or adequacy of any information provided to Purchaser or the fairness of the terms of its investment in the Series G Units. 

(f) Purchaser has had an opportunity to ask questions and receive answers concerning the terms and conditions of the
offering of the Series G Units and has had full access to such other information concerning the Company as has been requested. 
 (g) This Agreement constitutes the legal, valid and binding obligation of Purchaser, enforceable in accordance with its terms, and the execution, delivery and performance of this Agreement by Purchaser
does not and will not conflict with, violate or cause a breach of any agreement, contract or instrument to which Purchaser is a party or any judgment, order or decree to which Purchaser is subject. 

(h) Purchaser became aware of the offering of the Series G Units other than by means of general advertising or general
solicitation. 
 (i) Purchaser is an “accredited investor” as that term is defined under
the 1933 Act and Regulation D promulgated thereunder, as amended by Section 413 of the Private Fund Investment Advisers Registration Act of 2010 and any applicable rules or regulations or interpretations thereof promulgated by the SEC or
its staff. 
 (j) Purchaser acknowledges that the certificates for the Series G Preferred Stock and Common Stock
comprising the Series G Units will contain a legend substantially as follows: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE. THE SECURITIES MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS. 

  
 - 4 -

 THE COMPANY MAY REQUEST A WRITTEN OPINION OF COUNSEL (WHICH OPINION AND COUNSEL SHALL BE REASONABLY
SATISFACTORY TO THE COMPANY) TO THE EFFECT THAT REGISTRATION IS NOT REQUIRED IN CONNECTION WITH AN OFFER, SALE OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE.” 

Subject to any lock-up or other similar agreement that may apply to the Series G Units, the requirement that the Series G Units contain
the legend set forth in clause (j) above shall cease and terminate upon the earlier of (i) when such shares are transferred pursuant to Rule 144 under the 1933 Act or (ii) when such securities are transferred in any other transaction
if the transferor delivers to the Company a written opinion of counsel (which opinion and counsel shall be reasonably satisfactory to the Company) to the effect that such legend is no longer necessary in order to protect the Company against a
violation by it of the 1933 Act upon any sale or other disposition of such securities without registration thereunder. Upon the consummation of an event described in (i) or (ii) above, the Company, upon surrender of certificates containing
such legend, shall, at its own expense, deliver to the holder of any such securities as to which the requirement for such legend shall have terminated, one or more new certificates evidencing such securities not bearing such legend. 

6. Exchange for Newly Issued Securities. 
 At any time on or prior to November 17, 2013, if the Company issues any securities (whether debt, equity or otherwise), other than pursuant to the Company’s Amended and Restated Equity-Based
Compensation Plan or the Company’s 2011 Employee Stock Purchase Plan (or any additional or successor employee equity compensation arrangements) or a Subsequent Transaction (as defined below), (any such securities, “Additional
Securities”) on terms (economic or otherwise) that PCA LSG Holdings, LLC, a Delaware limited liability company (“PCA Holdings”), in its sole reasonable discretion, determines are more favorable than the Series G
Units, Purchaser may exchange all, but not less than all, of its Series G Units for such newly issued Additional Securities. Each Series G Unit to be exchanged shall be valued at the then present Liquidation Value of the Series G Preferred Stock
included in such Series G Unit. The Company shall, as soon as practicable, but in no event later than 10 days prior to the to the issue of Additional Securities, deliver written notice to Purchaser stating (i) the terms of such Additional
Securities and (ii) the Company’s calculation of the number of such Additional Securities that would be issued in exchange for one Series G Unit. If PCA Holdings determines, pursuant to this Section 6, that such issuance of
Additional Securities is on terms more favorable than the Series G Units, PCA Holdings shall have 10 days from the receipt of such notice from the Company to deliver notice to the Company and Purchaser of such determination and if Purchaser elects
to exercise its right to exchange its Series G Units pursuant to the terms of this Section 6, it shall be required to surrender to the Company all certificate(s) evidencing the shares of Series G Preferred Stock and the shares of Common
Stock underlying the Series G Units to be exchanged in accordance with this Section 6. Notwithstanding anything to the contrary herein, if Purchaser elects to exchange its Series G Units pursuant to this Section 6, it hereby
agrees that PCA Holdings shall have the right to enter into such agreements, make such amendments hereto and take such other actions on behalf of Purchaser in order to give effect to this Section 6. For the avoidance of doubt, the rights
granted to PCA Holdings under this Section 6 shall not apply to the Additional Securities issued in a Subsequent Transaction. 

  
 -5-

 7. Subsequent Securities Sales. 

(a) At least five days prior to the closing of the first sale of any securities of the Company (whether debt, equity or
otherwise) that when aggregated with all other securities of the Company (whether debt, equity or otherwise) issued and sold thereby since December 1, 2011, other than pursuant to the Company’s Amended and Restated Equity-Based
Compensation Plan or the Company’s 2011 Employee Stock Purchase Plan (or any additional or successor employee equity compensation arrangements) or that certain Series G Unit Subscription Agreement, dated as of December 1, 2011, by and
among the Company and the other parties thereto, results in gross proceeds to the Company of at least $50,000,000.00 in the aggregate (a “Subsequent Transaction”), and for so long as Purchaser holds any of the shares of
Series G Preferred Stock purchased hereby, the Company shall give notice of such Subsequent Transaction to Purchaser setting forth the terms and conditions of such Subsequent Transaction. The Company shall not enter into an agreement for a
Subsequent Transaction unless such agreement permits the Company to comply with this Section 7 and Section 4 of the Certificate of Designation of Series G Preferred Stock of the Company dated December 1, 2011 (the
“Certificate of Designation”). 
 (b) Simultaneous with and subject to the closing of the
Subsequent Transaction, if any, Purchaser shall have the right, but not the obligation: 
  

	 	i.	to the extent not prohibited by the terms of the securities issued in the Subsequent Transaction, to require the Company to use the proceeds of such Subsequent
Transaction to redeem Purchaser’s Series G Preferred Stock in accordance with Section 4(b)(i) of the Certificate of Designation; or 

  

	 	ii.	to elect to convert all or less than all of Purchaser’s Series G Preferred Stock in accordance with Section 4(b)(ii) of the Certificate of Designation (a
“Conversion”). 

  

	 	(c)	For the avoidance of doubt, if the Series G Preferred Stock is redeemed, repurchased, exchanged or converted, including but not limited to pursuant to this
Section 7 or pursuant to the Company’s rights and obligations under the Certificate of Designation, for any reason other than in connection with an exchange of Series G Units pursuant to Section 6 of this Agreement, the
holder of such Series G Units shall retain all of the Common Stock that was part of any Series G Unit of which the Series G Preferred Stock is subject to such redemption, repurchase, exchange or conversion. 

  
 - 6 -

 8. Indemnification by the Company. The Company shall save, defend, indemnify and hold
harmless Purchaser and its affiliates and the respective representatives, successors and assigns of each of the foregoing from and against any and all losses, damages, liabilities, deficiencies, claims, diminution of value, interest, awards,
judgments, penalties, costs and expenses (including attorneys’ fees, costs and other out-of-pocket expenses incurred in investigating, preparing or defending the foregoing), asserted against, incurred, sustained or suffered by any of the
foregoing as a result of, arising out of or relating to any breach of any representation, warranty or covenant made by the Company and contained in this Agreement and the schedule hereto. 
 9. General Provisions. 
 (a) Choice of Law. The laws
of the State of New York without reference to the conflict of laws provisions thereof, will govern all questions concerning the construction, validity and interpretation of this Agreement. 

(b) Amendment and Waiver. The provisions of this Agreement may be amended and waived only with the prior written
consent of the Company and Purchaser. 
 (c) Counterparts. This Agreement may be executed in counterparts,
each of which shall be an original and all of which shall constitute a single agreement. 
 (d) Acceptance by
the Company. It is understood that this subscription is not binding on the Company until the Company accepts it, which acceptance is at the sole discretion of the Company and shall be noted by execution of this Agreement by the Company where
indicated. 
 (e) Headings. The headings contained in this Agreement are inserted for convenience only and
will not affect in any way the meaning or interpretation of this Agreement. 
 (f) Stockholder. Purchaser
hereby acknowledges that, once accepted by the Company, this subscription is not revocable by it. Purchaser agrees that, if this subscription is accepted, it shall, and it hereby elects to: (i) become a stockholder of the Company; (ii) be
bound by the terms and provisions hereof; and (iii) execute any and all further documents when and as reasonably requested by the Company in connection with the transactions contemplated by this Agreement. 

* * * * * 

  
 - 7 -

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of
the date first written above. 
  

			
	 COMPANY:
  

LIGHTING SCIENCE GROUP CORPORATION

		
	By:	 	/s/ Zvi Raskin
	Name:	 	Zvi Raskin
	Title:	 	General Counsel and Secretary

  
 [Signature
Page to Series G Unit Subscription Agreement] 

 PURCHASER: 

/s/ Leon
Wagner                                        
         
 Leon Wagner 

  
 [Signature
Page to Series G Unit Subscription Agreement]Traffix Communication Systems Ltd. 2007 Israeli Employee Share Option Plan

 Exhibit 10.1 
 F5 NETWORKS, INC. 
 ASSUMED
TRAFFIX COMMUNICATION SYSTEMS LTD. 
 2007 ISRAELI EMPLOYEE
SHARE OPTION PLAN 

 PREFACE 
 On February 21, 2012, F5 Networks, Inc. (the “Company”) acquired all of the outstanding capital stock of Traffix Communication Systems Ltd. (“Traffix”) (the
“Acquisition”). In connection with the Acquisition, the Company assumed the Traffix 2007 Israeli Employee Share Option Plan, which the Company has amended as set forth herein. This plan, as amended from time to time, shall be known
as the “Assumed Traffix 2007 Israeli Employee Share Option Plan” (the “ESOP”). 
  

	1.	PURPOSE OF THE ESOP 

 The
purpose of this ESOP is to foster and promote the long-term financial success of the Company and its Affiliates and increase shareholder value by: 
 (a) motivating superior performance by means of performance-related incentives; 

(b) encouraging and providing for the acquisition of an ownership interest in the Company by eligible Employees; and 

(c) enabling the Company to attract and retain the services of outstanding management team and other qualified and dedicated employees
upon whose judgment, interest and special effort the successful conduct of its operations is largely dependent. 
  

	2.	DEFINITIONS 

 For purposes
of this ESOP and related documents, including the Grant Letter, the following definitions shall apply: 
  

	 	2.1	“Administrator”—means the Board or the Committee as shall be administering this ESOP, in accordance with Section 3 hereof.

  

	 	2.2	“Affiliate”—means any “employing company” within the meaning of Section 102(a) of the Ordinance. 

 

	 	2.3	“Approved 102 Option”—means an Option granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of
the Optionee. 

  

	 	2.4	“Articles of Incorporation”—means the Articles of Incorporation of the Company as same are in effect from time to time. 

 

	 	2.5	“Board”—means the Board of Directors of the Company. 

 

	 	2.6	“Capital Gain Option” or “CGO”—as defined in Section 5.4 below. 

 

	 	2.7	 “Cause”—means, with respect to an Employee (i) as such term is defined in the individual employment agreement or other
engagement agreement between the Employee and Traffix or its Affiliates, or (ii) if no such agreement is in place, then ‘Cause’ shall mean any one of the following: (a) conviction of any felony

	 	
involving moral turpitude or affecting Traffix or its Affiliates; (b) any failure to carry out, as an employee of the Traffix or its Affiliates, a reasonable directive of the chief executive
officer, the Board or the Optionee’s direct supervisor, which involves the business of Traffix or its Affiliates and which was capable of being lawfully performed by Optionee; (c) embezzlement or theft of funds of Traffix or its
Affiliates; (d) any breach of the Optionee’s fiduciary duties or duties of care of Traffix; including, without limitation, self-dealing, prohibited disclosure of confidential information of, or relating to, Traffix or its Affiliates, or
engagement in any business competitive to the business of Traffix or of its Affiliates; (e) any conduct (other than conduct in good faith) reasonably determined by the Board to be materially detrimental to Traffix or its Affiliates, and
(f) any other circumstances under which Traffix or its Affiliates is entitled to terminate Optionee’s employment with Traffix or such Affiliate without paying Optionee severance pay under applicable law; and with respect to a Non-Employee
(i) as such term is defined in the individual engagement agreement between the Optionee and Traffix or its Affiliates, or (ii) if no such agreement is in place, then ‘Cause’ shall mean any one of the circumstances set forth in
(a) through and including (e) herein, as applicable to such Non-Employee. 

  

	 	2.8	“Chairman”—means the chairman of the Committee. 

  

	 	2.9	“Committee”—means a share option compensation committee appointed by the Board, which shall consist of no fewer than two members of the Board, and
if no such compensation committee is appointed, then the Board. 

  

	 	2.10	“Common Stock” – means common stock of the Company, no par value per share. 

 

	 	2.11	“Company”—means F5 Networks, Inc., a Washington corporation. 

 

	 	2.12	“Companies Law”—means the Israeli Companies Law, 5759-1999, including any rules and regulations promulgated thereunder and any provisions of the
Companies Ordinance [New Version], 1983 still in effect, as amended from time to time. 

  

	 	2.13	“Controlling Shareholder”—shall have the meaning ascribed to it in Section 32(9) of the Ordinance. 

 

	 	2.14	“Date of Grant”—means, the date of grant of an Option, as determined by the Board and set forth in the Optionee’s Grant Letter, and in any
event not earlier than the first date on which the Company is permitted to effect Option grants under this ESOP and the provisions of the Ordinance. 

  

	 	2.15	“Employee”—means a person who is employed by Traffix or its Affiliates, including an individual who is serving as a director or an office holder,
but excluding Controlling Shareholder. 

	 	2.16	“Expiration Date”—means the date upon which an Option shall expire, as set forth in Section 9.2 of this ESOP. 

 

	 	2.17	“Fair Market Value”—means as of any date, the value of a Share determined as follows: 

 

	 	2.17.1	If the Shares are listed on any established stock exchange or a national market system, including without limitation the NASDAQ Global Select Market, the NASDAQ Global
Market or the NASDAQ Capital Market, the Fair Market Value shall be the closing sales price for such Shares (or the closing bid, if no sales were reported), as quoted on such exchange or system for the last market trading day prior to time of
determination, as reported in the Wall Street Journal, or such other source as the Board deems. 

  

	 	2.17.2	Without derogating from the above, solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, if at the Date of Grant
the Company’s shares are listed on any established stock exchange or a national market system or if the Company’s shares will be registered for trading within ninety (90) days following the Date of Grant, the Fair Market Value of a
Share at the Date of Grant shall be determined in accordance with the average value of the Company’s shares on the thirty (30) trading days preceding the Date of Grant or on the thirty (30) trading days following the date of
registration for trading, as the case may be; 

  

	 	2.17.3	If the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value shall be the mean between the high bid
and low asked prices for the Shares on the last market trading day prior to the day of determination, or; 

  

	 	2.17.4	In the absence of an established market for the Shares, the Fair Market Value thereof shall be determined in good faith by the Board. 

 

	 	2.18	“Grant Letter” means the grant letter given by the Company to the Optionee and signed by the Optionee, and which sets out the terms and conditions of
an Option. 

  

	 	2.19	“ESOP”—means as defined in the preface hereto. 

  

	 	2.20	“ITA”—means the Israeli Tax Authorities. 

  

	 	2.21	“NIS” —means, New Israeli Shekels. 

  

	 	2.22	“Non-Employee”—means a consultant, adviser, service provider, Controlling Shareholder or any other person who is not an Employee.

  

	 	2.23	“Ordinary Income Option” or “OIO”—as defined in Section 5.5 below. 

	 	2.24	“Option”—means an option to purchase one or more Shares of the Company pursuant to this ESOP. 

 

	 	2.25	“102 Option”—means an Option that the Board intends to be a “102 Option” which shall only be granted to Employees who are not Ten
Percent shareholders, and shall be subject to and construed consistently with the requirements of Section 102 of the Tax Ordinance. The Company shall have no liability to an Optionee, or to any other party, if an Option (or any part thereof),
which is intended to be a 102 Option, does not eventually qualify as a 102 Option. Approved 102 Options may either be classified as Capital Gain Options (CGO) or Ordinary Income Options (OIO). 

 

	 	2.26	“3(i) Option”—means Options that do not contain such terms as will qualify under Section 102 of the Tax Ordinance. 

 

	 	2.27	“Optionee”—means a person who receives or holds an Option under this ESOP. 

 

	 	2.28	“Ordinance”—means the Israeli Income Tax Ordinance [New Version] 1961, including any and all rules and regulations promulgated thereunder, as now
in effect or as hereafter amended. 

  

	 	2.29	“Purchase Price”—means the purchase price for each Share underlying an Option. 

 

	 	2.30	“Section 102”—means Section 102 of the Ordinance, including any and all rules, regulations, orders and procedures promulgated thereunder, as
now in effect or as hereafter amended. 

  

	 	2.31	“Share”—means a share of Common Stock of the Company. 

 

	 	2.32	“Successor Company”—means any entity into or with which the Company is merged or by which, the Company is acquired, pursuant to a Transaction in
which the Company is not the surviving entity. 

  

	 	2.33	“Traffix” —means Traffix Communication Systems Ltd., a company incorporated under the laws of the State of Israel, corporate registration number
513768762. 

  

	 	2.34	“Transaction” —means, each (i) merger, acquisition or reorganization of the Company with one or more other entities in which the Company is
not the surviving entity, or (ii) a sale of all or substantially all of the assets or shares of the Company. 

  

	 	2.35	“Trustee”—means any individual appointed by the Company to serve as a trustee and approved by the ITA, all in accordance with the provisions of
Section 102(a) of the Ordinance. 

  

	 	2.36	“US$” —means, United States of America dollars. 

	 	2.37	“Vested Option” —means any Option that has already become vested and exercisable according to its Vesting Dates or otherwise (e.g. acceleration
upon certain events). 

  

	 	2.38	“Vesting Dates”—means, with respect to any Option, the date(s) as of which the Optionee shall be entitled to exercise such Option, as set forth
Optionee’s individual Grant Letter, and if no such date(s) are specified in Optionee’s individual Grant Letter, then as set out in Section 10.2 of this ESOP. 

 

	 	2.39	“Unapproved 102 Option”—means an Option granted pursuant to Section 102(c) of the Ordinance and not held in trust by a Trustee.

  

	3.	ADMINISTRATION OF THIS ESOP 

 This ESOP shall be administered by the Board. The Board shall have the authority in its sole discretion, subject and not inconsistent with the express provisions of this ESOP, to administer this ESOP and
to exercise all the powers and authorities specifically granted to it under this ESOP as necessary and advisable in the administration of this ESOP. 
 Provided that the Board is entitled by law to delegate all and any of its powers and authority granted to it under this ESOP to a Committee, then such powers and authority may be delegated to the
Committee. The Committee shall have the responsibility of construing and interpreting this ESOP and of establishing and amending such rules and regulations, as it deems necessary or desirable for the proper administration of this ESOP. 

 

	 	3.1	The Committee shall select one of its members as its Chairman and shall hold its meetings at such times and places, as the Chairman shall determine or as otherwise
convened in accordance with the Articles of Incorporation. The Committee shall keep records of its meetings and shall make such rules and regulations for the conduct of its business, as it shall deem advisable. 

 

	 	3.2	The Committee shall have the power to recommend to the Board and the Board shall have the full power and authority to: (i) designate Optionees; (ii) determine
the, Date of Grant, terms and provisions of the respective Grant Letters (which need not be identical), including, but not limited to, the number of Options to be granted to each Optionee, the number of Shares to be covered by each Option,
provisions concerning the time and extent to which the Options may be exercised, and the nature and duration of restrictions as to the transferability, or restrictions constituting substantial risk of forfeiture upon occurrence of certain events;
(iii) determine the Fair Market Value of the Shares covered by each Option; (iv) designate the type of Options; and (v) cancel or suspend Options, as necessary. 

	 	3.3	Subject to the provisions of this ESOP, the applicable laws and, the specific duties delegated by the Board to the Committee, and subject to the approval of any
relevant authorities, the Committee shall have the authority, in its discretion: 

  

	 	(i)	To construe and interpret the terms of this ESOP and any Options granted pursuant hereto; 

 

	 	(ii)	To designate the Employees and Non-Employees to whom Options may from time to time be granted hereunder; 

 

	 	(iii)	To determine the number of Shares to be covered by each such Option granted hereunder; 

 

	 	(iv)	To prescribe forms of agreements and/or Grant Letters for use under this ESOP; 

 

	 	(v)	To determine the terms of any Option granted hereunder; 

  

	 	(vi)	To determine the Purchase Price of any Option granted hereunder; 

  

	 	(vii)	To determine the Fair Market Value of Shares; 

  

	 	(viii)	To prescribe, amend and rescind rules and regulations relating to this ESOP, provided that any such amendment or rescindment that would adversely affect the rights of
an Optionee that has received or been granted an Option shall not be made without the Optionee’s written consent. 

  

	 	(ix)	To take all other action and make all other determinations necessary for the administration of this ESOP. 

 

	 	(x)	To determine the total number of Shares with in the pool allocated for the purpose of this ESOP from time to time, and or any additional awards hereafter, subject to
this ESOP. 

  

	 	3.4	Subject to the Articles of Incorporation, all decisions and selections made by the Board or the Committee pursuant to the provisions of this ESOP shall be made by a
majority of its members except that no member of the Board or the Committee shall vote on, or be counted for quorum purposes, with respect to any proposed action of the Board or the Committee relating to any Option to be granted to that member. Any
decision reduced to writing shall be executed in accordance with the provisions of the Articles of Incorporation, as the same may be in effect from time to time. 

 

	 	3.5	Any decision or action taken or to be taken by the Committee, arising out of or in connection with the construction, administration, interpretation and effect of this
ESOP and of its rules and regulations, shall, to the maximum extent permitted by applicable law, be within its absolute discretion (except as otherwise specifically provided herein) and shall be conclusive and binding upon all Optionees and any
person claiming under or through any Optionee. 

	 	3.6	No member of the Board or the Committee shall be liable for any action taken or determination made in good faith with respect to this ESOP or any Option granted
hereunder. 

  

	 	3.7	Any member of such Committee shall be eligible to receive Options under this ESOP while serving on the Committee, unless otherwise specified herein. No person shall be
eligible to be a member of the Committee if that person’s membership would prevent this ESOP from complying with exemptions provided under applicable laws. 

 

	4.	DESIGNATION OF OPTIONEES 

  

	 	4.1	The persons eligible for participation in this ESOP as Optionees shall include any Employees and/or Non-Employees of Traffix or of its Affiliates on or prior to
February 21, 2012; provided, however, that (i) Employees may only be granted 102 Options; and (ii) Non-Employees may only be granted 3(i) Options. 

 

	 	4.2	Each Option granted pursuant to this ESOP shall be evidenced by a Grant Letter, in such form as is customarily used by the Company for such purpose. Each Grant Letter
shall state, among other matters, the number of Shares to which the Option relates, the type of Option granted thereunder (whether an CGO, OIO, Unapproved 102 Option or a 3(i) Option), the Vesting Dates, the Purchase Price per share, the Expiration
Date and such other terms and conditions as are customarily included in such letters or option agreements, including any such other terms that the Committee or the Board in their discretion may prescribe, provided in all cases that they are
consistent with this ESOP. The Grant Letter shall be delivered to the Optionee and executed by the Optionee and shall incorporate the terms of this ESOP by reference and specify the terms and conditions thereof and any rules applicable thereto.

  

	 	4.3	Neither this ESOP nor any Grant Letter nor any offer of Options to an Optionee shall impose any obligation on Traffix or its Affiliates to continue to employ or to
engage the services of any Optionee, and nothing in this ESOP or in any Option granted pursuant thereto shall give any Optionee any right to continued employment, service with or engagement by Traffix or its Affiliates or restrict the right of
Traffix or its Affiliates to terminate such employment, services or engagement at any time. Further, the Company and each Affiliate expressly reserves the right at any time to dismiss an Optionee free from any liability, or any claim under this
ESOP, except as provided herein or in any agreement entered into with respect to an Option. 

  

	 	4.4	The grant of an Option hereunder shall neither entitle the Optionee to participate nor disqualify the Optionee from participating in, any other grant of Options
pursuant to this ESOP or any other option or share plan of the Company or any of its Affiliates. 

	 	4.5	Notwithstanding anything in the ESOP to the contrary, all grants of Options to directors and office holders shall be authorized and implemented in accordance with the
provisions of the Companies Law. 

  

	5.	DESIGNATION OF OPTIONS PURSUANT TO SECTION 102 

  

	 	5.1	The Company may designate Options granted to Employees pursuant to Section 102 as Unapproved 102 Options or Approved 102 Options. 

 

	 	5.2	The grant of Approved 102 Options under this ESOP shall be made in accordance with the provisions herein, including the provisions of Section 6 below, and shall be
conditioned upon the approval of this ESOP by the ITA. 

  

	 	5.3	Approved 102 Option may either be classified as Capital Gain Option (CGO) or Ordinary Income Option (OIO). 

 

	 	5.4	Approved 102 Option elected and designated by the Company to qualify under the capital gain tax treatment in accordance with the provisions of Section 102(b)(2)
shall be referred to herein as CGO. 

  

	 	5.5	Approved 102 Option elected and designated by the Company to qualify under the ordinary income tax treatment in accordance with the provisions of Section 102(b)(1)
shall be referred to herein as OIO. 

  

	 	5.6	The Company’s election of the type of Approved 102 Options as CGO or OIO granted to Employees (the “Election”) shall be appropriately filed with the ITA
before the first Date of Grant of an Approved 102 Option under such Election. Such Election shall become effective beginning the first Date of Grant of an Approved 102 Option under such Election and shall remain in effect until the end of the year
following the year during which the Company first granted Approved 102 Options under such Election. The Election shall obligate the Company to grant only the type of Approved 102 Option it has elected, and shall apply to all Optionees who were
granted Approved 102 Options during the period indicated herein, all in accordance with the provisions of Section 102(g) of the Ordinance. For avoidance of doubt, such Election shall not prevent the Company from granting Unapproved 102 Options
simultaneously. 

  

	 	5.7	Designation of Approved 102 Options – if an Optionee exercises and sells his Shares within the Restricted Period (as defined in Section 6.1 below), the
Company shall not bare any tax liability arising due to the exercise and or sale of such Shares resulting from Optionee’s termination of employment, except for the tax liability mentioned in Section 21 below. 

 

	 	5.8	All Approved 102 Options must be held in trust by the Trustee, as described in Section 6 below. 

	 	5.9	For avoidance of doubt, the designation of Unapproved 102 Options and Approved 102 Options shall be subject to the terms and conditions set forth in Section 102 of
the Ordinance. 

  

	6.	TRUSTEE 

  

	 	6.1	Approved 102 Options which shall be granted under this ESOP and/or any Shares allocated or issued upon exercise of such Approved 102 Options and/or other shares
received subsequently following any realization of rights, including, without limitation, bonus shares, shall be allocated or issued to or controlled by the Trustee and held or controlled by the Trustee for the benefit of the Optionees to whom such
Approved 102 Options were granted for at least such period of time as required by Section 102 (the “Restricted Period”). If the requirements for Approved 102 Options are not met, the Approved 102 Options may be treated as Unapproved
102 Options, all in accordance with the provisions of Section 102. 

  

	 	6.2	Notwithstanding anything to the contrary herein, the Trustee shall not allow the release of any Shares allocated or issued upon exercise of Approved 102 Options prior
to the full payment of the Optionee’s tax liabilities arising from Approved 102 Options, which were granted to such Optionee and/or any Shares allocated or issued upon exercise of such Options. 

 

	 	6.3	With respect to any Approved 102 Option, subject to the provisions of Section 102, an Optionee shall not sell or release from trust any Share received upon the
exercise of an Approved 102 Option and/or any share received subsequently following any realization of rights, including without limitation, bonus shares, until the lapse of the Restricted Period required under Section 102. Notwithstanding the
above, if any such sale or release occurs during the Restricted Period, the sanctions under Section 102 shall apply to and shall be borne by such Optionee. 

 

	 	6.4	Upon receipt of Approved 102 Option, the Optionee will sign an undertaking to release the Trustee from any liability in respect of any action or decision duly taken and
bona fide executed in relation with this ESOP, or any Approved 102 Option or Share granted to him hereunder. Such release may be incorporated into the Grant Letter. 

 

	7.	SHARES RESERVED FOR THE ESOP 

  

	 	7.1	Subject to the adjustments set forth in Section 11 below, the number of Shares that may be issued pursuant to this ESOP shall not exceed in the aggregate 106,829
Shares. Should any Option for any reason expire or be canceled prior to its exercise or relinquishment in full, the Shares subject to such Option may again be subjected to a new Option under this ESOP, provided, however, that Shares that have
actually been issued under this ESOP shall not be returned to the pool under this ESOP and shall not become available for future distribution under this ESOP. 

	8.	PURCHASE PRICE 

  

	 	8.1	The Purchase Price of each Share subject to an Option shall be equal to the Share’s Fair Market Value or as otherwise determined by the Committee in its sole and
absolute discretion in accordance with applicable law, subject to any guidelines as may be determined by the Board from time to time. Each Grant Letter will contain the Purchase Price determined for each Option covered thereby (but in any event, not
less than the nominal value of the Share issuable upon exercise thereof). 

  

	 	8.2	The total consideration to be paid for the Shares to be issued upon exercise of an Option, including the method of payment, shall be determined by the Administrator and
may consist entirely of (1) cash, (2) check, or (3) any combination of the foregoing methods of payment, or (4) if, as of the date of exercise of an Option the Company then is permitting Employees to engage in a “same-day
sale” cashless brokered exercise program involving one or more brokers, through such a program that complies with the Applicable Laws (including without limitation the requirements of Regulation T and other applicable regulations promulgated by
the Federal Reserve Board) and that ensures prompt delivery to the Company of the amount required to pay the exercise price and any applicable withholding taxes,. In making its determination as to the type of consideration to accept, the
Administrator shall consider if acceptance of such consideration may be reasonably expected to benefit the Company. The Committee shall have the authority to postpone the date of payment on such terms as it may determine. 

 

	 	8.3	The Purchase Price shall be denominated in NIS or US$ or otherwise as determined by the Committee. 

 

	 	8.4	The proceeds received by the Company from the issuance of Shares subject to the Options will be added to the general funds of the Company and used for its corporate
purposes. 

  

	9.	TERM AND EXERCISE OF OPTIONS 

  

	 	9.1	Options shall be exercised by the Optionee by giving written notice to the Company and/or to any third party designated by the Company (the “Representative”),
in such form and method as may be determined by the Committee and when applicable, by the Trustee in accordance with the requirements of Section 102, which exercise shall be effective upon receipt of such notice by the Company and/or the
Representative and the payment of the Purchase Price at the Company’s or the Representative’s principal office. The notice shall specify the number of Shares with respect to which the Option is being exercised. 

 

	 	9.2	Options, to the extent not previously exercised, shall terminate forthwith upon the earlier of: (i) the date set forth in the Grant Letter as determined by the
Board; or (ii) the expiration of any extended period in any of the events set forth in Section 9.5 below. 

	 	9.3	The Options may be exercised by the Optionee in whole at any time or in part from time to time, to the extent that the Options become vested and exercisable, prior to
the Expiration Date, and provided that, subject to the provisions of Section 9.5 below, the Optionee who is an Employee is employed by or providing services to Traffix or any of its Affiliates, at all times during the period beginning with the
granting of the Option and ending upon the date of exercise. An Optionee who is a Non-Employee may exercise the Options in whole at any time or in part from time to time, to the extent that the Options have become vested and exercisable, prior to
the Expiration Date. 

  

	 	9.4	Subject to the provisions of Section 9.5 below, in the event of termination of Optionee’s employment or services with Traffix or any of its Affiliates, all
Options granted to such Optionee that are at the time of termination non-vested will immediately expire. A notice of termination of employment or service shall be deemed to constitute termination of employment or service. For the avoidance of doubt,
in case of such termination of employment or service, the unvested portion of the Optionee’s Option shall not vest and shall not become exercisable and any unvested portion of the Optionee’s Option shall revert to the pool of Shares under
this ESOP or that of other share option plans then in effect. 

  

	 	9.5	Notwithstanding anything to the contrary herein and unless otherwise determined in the Optionee’s Grant Letter, an Option may be exercised after the date of
termination of Optionee’s employment or service with Traffix or any Affiliates during an additional period of time beyond the date of such termination, but only with respect to the number of Vested Options at the time of such termination
according to the Vesting Dates, as follows: 

  

	 	(i)	If termination is without Cause, then any Vested Option still in force and un-expired may be exercised within a period of three (3) months after the date of such
termination; 

  

	 	(ii)	If termination is the result of death, or Disability (defined below) of the Optionee, then any Vested Option still in force and un-expired may be exercised within a
period of twelve (12) months after the date of such termination; 

  

	 	(iii)	With respect to (i) and (ii) above, prior to the expiration of the periods set out therein (i.e., the 3-month period in (i) above, and the 12-month
period in (ii) above), the Committee may authorize an extension of the terms of exercise post-termination of all or part of the Vested Options beyond the date of such termination for a period not to exceed the period during which the Options by
their terms would otherwise have been exercisable. 

	 	(iv)	For avoidance of any doubt, notwithstanding anything herein to the contrary, if termination of employment or service is for Cause, any outstanding unexercised Option
(whether vested or non-vested), will immediately expire and terminate, and the Optionee shall not have any right in connection to such outstanding Options. 

 

	 	(v)	As used herein: the term “Disability” shall have the meaning ascribed thereto in the individual employment or engagement agreement between the Optionee
and Traffix or any of its Affiliates, as applicable and if no such definition exists, then ‘Disability’ shall mean Optionee’s inability to perform his/her duties to Traffix, or to any of its Affiliates, for a consecutive period of at
least 180 days, by reason of any medically determinable physical or mental impairment. 

  

	 	9.6	To avoid doubt, the Optionees shall not be deemed owners of the Shares issuable upon the exercise of Options and shall not have any of the rights or privileges of
shareholders of the Company in respect of any Shares purchasable upon the exercise of any Option, nor shall they be deemed to be a class of shareholders of the Company for any purpose, including but not limited for the purpose of the operation of
Sections 350 and 351 of the Companies Law or any successor to such section, until registration of the Optionee as holder of such Shares in the Company’s register of shareholders upon exercise of the Option in accordance with the provisions of
this ESOP, but in case of Options and Shares held by the Trustee, subject to the provisions of Section 6 of this ESOP. Notwithstanding anything herein to the contrary, in no event shall the Optionees be deemed a class of creditors of the
Company for any purpose whatsoever, including but not limited to for the purpose of the operation of Sections 350 and 351 of the Companies Law or any successor to such section. 

 

	 	9.7	Any form of Grant Letter customarily used by the Company in connection with the grant of Options, provided it is consistent with the provisions of this ESOP, may
contain such other provisions, as the Committee or the Board may, from time to time, deem advisable. 

  

	 	9.8	The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary
for the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained. 

 

	 	9.9	With respect to Unapproved 102 Options, if the Optionee ceases to be employed by the Company or any Affiliate, the Optionee shall extend to the Company and/or its
Affiliate a security or guarantee for the payment of tax due at the time of sale of Shares, all in accordance with the provisions of Section 102. In respect of any employer’s tax liability for the purpose of employment taxes such as in the
case of social taxes, see Section 21 below. 

	 	9.10	Shares shall not be issued pursuant to the exercise of an Option unless the exercise of such Option, the method of payment and the issuance and delivery of such Shares
shall comply with applicable laws. 

  

	 	9.11	Upon their issuance, the Shares shall carry equal voting rights on all matters where such vote is permitted by applicable laws of the jurisdiction of incorporation of
the Company. 

  

	10.	VESTING OF OPTIONS 

  

	 	10.1	Subject to the provisions of this ESOP, each Option shall vest and become exercisable commencing on the Vesting Date thereof, as determined by the Board or by the
Committee, for the number of Shares as shall be provided in the Grant Letter. However, no Option shall be exercisable after the Expiration Date. 

  

	 	10.2	Unless otherwise stated in the Optionee’s Grant Letter, all Options granted pursuant to this ESOP, shall vest semi-annually, in eight (8) equal portions, over
a 4-year period from its Date of Grant, with twelve and one half percent (12.5%) of such Option becoming vested at the end of each six (6) month period following the Date of Grant. 

 

	 	10.3	An Option may be subject to such other terms and conditions on the time or times when it may be exercised, as the Committee may deem appropriate. The vesting provisions
of individual Options may vary. 

  

	11.	ADJUSTMENTS 

  

	 	11.1	Changes in Capitalization. Subject to any required action by the shareholders of the Company, the number of Shares covered by each outstanding Option, the
number of Shares which have been reserved for issuance under this ESOP and/or any other share option plan adopted by the Company, but as to which no Options have yet been granted or which have been returned to this ESOP or such other share option
plans upon cancellation or expiration of an Option, as well as the Purchase Price per share of Shares covered by each such outstanding Option, shall be proportionately adjusted for any increase or decrease resulting from a share split, bonus shares
(share dividend), combination or reclassification of the Shares, or any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company. The adjustments described herein shall be made by the
Administrator, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and
no adjustment by reason thereof shall be made with respect to the number or the price of Shares subject to an Option. If the Options or the Shares issued upon the exercise of such Options will be deposited with a Trustee, as determined by the
Administrator, all of the Shares formed by these adjustments also will be deposited with the Trustee on the same terms and conditions as the original Options or Shares. 

	 	11.2	Dissolution or Liquidation. In the event of any dissolution or liquidation of the Company, whether voluntary or involuntary (the “Event”), the
Administrator shall notify each Optionee as soon as practicable prior to the effective date of such Event. The Option holders shall then have fifteen (15) days to exercise any unexercised Vested Options held by them at that time, in accordance
with the exercise procedure set forth herein. Upon the expiration of such 15-day period, all remaining unexercised Options and any non Vested Options will terminate immediately. The Administrator in its sole discretion may allow the exercise of any
or all-outstanding Options, whether or not such Options are Vested Options, during a longer period following such notification and prior to the Event, all subject to the provisions of applicable laws. To the extent it has not been previously
exercised, an Option and all Optionee’s rights thereto will terminate immediately prior to the Event. 

  

	 	11.3	Merger, Acquisition, Shares’ sale, Assets’ Sale 

 

	 	(a)	In the event of a Transaction, and to the extent possible by the terms of the Transaction, each outstanding Option shall be assumed for an equivalent option or right
substituted by the successor corporation or a parent or subsidiary of the successor corporation, and appropriate adjustments shall be made in the number of options in order to reflect such an action and to keep the Optionee harmless due to the
Transaction. 

  

	 	(b)	In the event that as part of the Transaction the successor corporation refuses to assume or substitute outstanding Options, the vesting periods defined in the Grant
Letters may be fully accelerated, in whole or in part, if so determined by the Board. In this event, the Administrator shall notify each Optionee in writing or electronically if and to what extent the Board has approved the acceleration of an
Option, and as to each Option that has been accelerated, the period of time during which the Vested Option may be exercised by the Optionee. The determination as to acceleration of any then un-Vested Options and the duration during which any Vested
Options may be exercised in connection with a Transaction shall be in the sole and absolute discretion of the Board. Subject to the following paragraph of this Section 11.3(b) below, any Vested Options shall be fully exercisable for such period
as determined by the Board, where any un-Vested or Vested but un-exercised Options shall terminate upon the expiration of such period. 

 In any event, any Vested Option not exercised by the date on which the definitive agreement for the Transaction has been executed (the “Cut-Off Date”), and any un-Vested Options on such Cut-Off
Date, shall immediately terminate and no longer be exercisable by the Optionee as of the Cut-Off Date. 
  

	 	(c)	 Without derogating from the provisions of paragraph (b) above, if as a condition precedent to a Transaction, all Optionees are required to sell or

	 	
exchange their Vested Options and/or any Shares issued upon exercise thereof as part of the Transaction, then each Optionee shall be obligated to sell or exchange, as the case may be, any Vested
Options and/or Shares such Optionee holds or purchased under this ESOP, in accordance with the instructions of the Board, at its sole and absolute discretion, in connection with the Transaction, and on the same terms as shall be determined to all
the holders of Common Stock in the Company. For avoidance of doubt, on the Cut-Off Date of a Transaction, any Vested Options not sold or exchanged and any non-Vested Options shall terminate and expire as of the Cut-Off Date.

  

	 	(d)	For the purposes of this paragraph, the Option shall be considered assumed if, following a Transaction, the Optionee receives the right to purchase or receive, for each
Share subject to the Option immediately prior to the Transaction, the consideration (whether in shares, stocks, cash, or other securities or property) received in the Transaction by holders of Shares for each Share held on the effective date of the
Transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the Transaction is not solely
shares of the successor corporation or its parent or subsidiary, the Administrator may, with the consent of the successor corporation, provide for each Optionee to receive solely Shares of the successor company or its parent or subsidiary equal in
Fair Market Value to the per share consideration received by holders of Shares in the Transaction. 

  

	 	11.4	Stock dividend, bonus shares, stock split 

  

	 	(a)	If the outstanding shares of the Company shall at any time be changed or exchanged by declaration of a share dividend (bonus shares), share split, combination or
exchange of shares, recapitalization, or any other like event by or of the Company, and as often as the same shall occur, then the number, class and kind of the Shares subject to this ESOP or subject to any Options therefor granted, and the Purchase
Prices, shall be appropriately and equitably adjusted so as to maintain the proportionate number of Shares without changing the aggregate Purchase Price, provided, however, that the Purchase Price shall not be less than the nominal value of the
Share underlying any such Options, and provided further, that no adjustment shall be made by reason of the distribution of subscription rights (rights offering) on outstanding shares. Upon the occurrence of any of the foregoing, the class and
aggregate number of Shares issuable pursuant to this ESOP (as set forth in Section 7 hereof), in respect of which Options have not yet been exercised, shall be appropriately adjusted, all as will be determined by the Board whose determination
shall be final. 

	 	(b)	Except as expressly provided herein, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no
adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Option. 

  

	12.	PURCHASE FOR INVESTMENT; REPRESENTATIONS 

  

	 	12.1	The Company’s obligation to issue or allocate Shares upon exercise of an Option granted under this ESOP is expressly conditioned upon: (a) the Company’s
completion of any registration or other qualifications of such Shares under all applicable laws, rules and regulations or (b) representations and undertakings by the Optionee (or his legal representative, heir or legatee, in the event of the
Optionee’s death) to assure that the sale of the Shares complies with any registration exemption requirements which the Company in its sole discretion shall deem necessary or advisable. Such required representations and undertakings may include
representations and agreements that such Optionee (or his legal representative, heir, or legatee): (a) is purchasing such Shares for investment and not with any present intention of selling or otherwise disposing thereof; and (b) agrees to
have placed upon the face and reverse of any certificates evidencing such Shares a legend setting forth (i) any representations and undertakings which such Optionee has given to the Company or a reference thereto and (ii) that, prior to
effecting any sale or other disposition of any such Shares, the Optionee must furnish to the Company an opinion of counsel, satisfactory to the Company, that such sale or disposition will not violate the applicable laws, rules, and regulations,
whether of the State of Israel or of any other State having jurisdiction over the Company and the Optionee. 

  

	 	12.2	Upon the grant of Options to an Optionee or the issuance of Shares upon the exercise thereof, the Company shall obtain from the Optionee the representations and
undertakings as follows, and any other representations and warranties that the Committee may deem advisable, and the giving of such representations and warranties by the Optionee shall be a condition precedent to Optionee’s right to receive the
Option and/or be issued the Shares upon exercise thereof: 

  

	 	(a)	That the Optionee knows that there is no certainty that the exercise of the Options will be financially worthwhile. The Optionee thereby undertakes not to have any
claim against the Company or any of its directors, employees, stockholders or advisors if it emerges, at the time of exercising the Options, that the Optionee’s investment in the Company’s Shares was not worthwhile, for any reason
whatsoever. 

  

	 	(b)	That the Optionee knows and understands that his rights regarding the Options and the Shares are subject for all intents and purposes to the instructions of the
Company’s documents of incorporation and to the agreements of the shareholders in the Company. 

	 	(c)	That the Optionee knows that in addition to the allocations set forth above, the Company has allocated and/or is entitled to allocate Options and Shares to other
employees and other people, and the Optionee shall have no claim regarding such allocations, their quantity, the relationship among them and between them and the other shareholders in the Company, exercising of the options or any matter related to
or stemming from them. 

  

	 	(d)	That the Optionee knows that neither this ESOP nor the grant of Option or Shares thereunder shall impose any obligation on Traffix or its Affiliates to continue the
engagement of the Optionee, and nothing in this ESOP or in any Option or Shares granted pursuant thereto shall confer upon any Optionee any right to continue being engaged by Traffix or its Affiliates, or restrict the right of Traffix or its
Affiliates to terminate such engagement at any time. 

  

	13.	DIVIDENDS 

 With respect
to all Shares (but excluding, for avoidance of any doubt, any unexercised Options) allocated or issued upon the exercise of Options purchased by the Optionee and held by the Optionee or by the Trustee, as the case may be, the Optionee shall be
entitled to receive dividends in accordance with the quantity of such Shares, subject to the provisions of the Articles of Incorporation and subject to any applicable taxation on distribution of dividends, and, when applicable, subject to the
provisions of Section 102. 
  

	14.	RESTRICTIONS ON ASSIGNABILITY AND SALE OF OPTIONS 

  

	 	14.1	No Option or any right with respect thereto, purchasable hereunder, whether fully paid or not, shall be assignable, transferable or given as collateral or any right
with respect to it given to any third party whatsoever, except as specifically allowed under this ESOP, and during the lifetime of the Optionee each and all of such Optionee’s rights to purchase Shares hereunder shall be exercisable only by the
Optionee. 

 Any such action made directly or indirectly, for an immediate validation or for a future one, shall be
void. 
  

	 	14.2	So long as Options and/or Shares are held by the Trustee on behalf of the Optionee, all rights of the Optionee over the Shares are personal, can not be transferred,
assigned, pledged or mortgaged, other than by will or pursuant to the laws of descent and distribution. 

  

	15.	EFFECTIVE DATE AND DURATION OF THE ESOP 

 This ESOP shall be effective as of February 21, 2012 and shall terminate on August 22, 2017, unless terminated earlier in accordance with Section 16 hereof. 

	16.	AMENDMENTS OR TERMINATION 

The Board may at any time, but when applicable, after consultation with the Trustee, amend, alter, suspend or terminate this ESOP. No
amendment, alteration, suspension or termination of this ESOP shall impair the rights of any Optionee, unless mutually agreed otherwise between the Optionee and the Company, which agreement must be in writing and signed by the Optionee and the
Company. Termination of this ESOP shall not affect the Committee’s ability to exercise the powers granted to it hereunder with respect to Options granted under this ESOP prior to the date of such termination. 

 

	17.	GOVERNMENT REGULATIONS 

This ESOP, and the grant and exercise of Options hereunder, and the obligation of the Company to sell and deliver Shares under such
Options, shall be subject to all applicable laws, rules, and regulations, whether of the State of Israel any other State having jurisdiction over the Company and the Optionee, including, without limitation, the United States Securities Act of 1933,
the Companies Law, the Securities Law, 1968, and the Ordinance, and to such approvals by any governmental agencies or national securities exchanges as may be required. Nothing herein shall be deemed to require the Company to register the Shares
under the securities laws of any jurisdiction. 
  

	18.	CONTINUANCE OF EMPLOYMENT OR HIRED SERVICES 

 Neither this ESOP nor the Grant Letter with the Optionee shall impose any obligation on Traffix or an Affiliate thereof, to continue any Optionee in its employ or service, and nothing in this ESOP or in
any Option granted pursuant thereto shall confer upon any Optionee any right to continue in the employ or service of Traffix or an Affiliate thereof or restrict the right of Traffix or an Affiliate thereof to terminate such employment or service at
any time. 
  

	19.	GOVERNING LAW & JURISDICTION 

 This ESOP shall be governed by and construed and enforced in accordance with the laws of the State of Israel applicable to contracts made and to be performed therein, without giving effect to the
principles of conflict of laws. The competent courts of Tel Aviv district, Israel shall have sole and exclusive jurisdiction in any matters pertaining to this ESOP and any Grant Letters effected hereunder. 

 

	20.	INTEGRATION OF SECTION 102 AND TAX COMMISSIONER’S PERMIT 

  

	 	20.1	With regards to Approved 102 Options, the provisions of this ESOP and the Grant Letter shall be subject to the provisions of Section 102 and the ITA
Commissioner’s permit, and the said provisions and permit shall be deemed an integral part of this ESOP and of the individual Grant Letters with each Optionee. 

 

	 	20.2	Any provision of Section 102 and/or the said permit which is necessary in order to receive and/or to keep any tax benefit pursuant to Section 102, which is
not expressly specified in this ESOP or the individual Grant Letter of the Optionees, shall be considered binding upon the Company and the Optionees. 

	21.	TAX CONSEQUENCES 

  

	 	21.1	Any tax consequences arising from the grant or exercise of any Option, from the payment for Shares covered thereby or from any other event or act (of the Company and/or
its Affiliates, the Trustee or the Optionee), hereunder, shall be borne solely by the Optionee. The Company and/or its Affiliates and/or the Trustee shall withhold taxes according to the requirements of any applicable laws, rules, and regulations,
including withholding taxes at source. Furthermore, the Optionee shall agree to indemnify the Company and/or its Affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty
thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Optionee. 

 

	 	21.2	The Company and/or, when applicable, the Trustee shall not be required to release any Share and/or share certificate representing such Shares to an Optionee until all
required payments have been fully made. 

  

	 	21.3	To the extent provided by the terms of any Grant Letter, the Optionee may satisfy any tax withholding obligation relating to the exercise or acquisition of Shares under
an Option by any of the following means (in addition to the Company’s right to withhold from any compensation paid to the Optionee by the Company) or by a combination of such means: (i) tendering a cash payment; (ii) subject to the
Committee’s approval on or prior to the payment date, authorizing the Company to withhold Shares from the Shares otherwise issuable to the Optionee as a result of the exercise or acquisition of Shares under the Option in an amount not to exceed
the minimum amount of tax required to be withheld by law; or (iii) subject to Committee approval on or prior to the payment date, delivering to the Company owned and unencumbered Shares; provided that Shares acquired on exercise of Options have
been held for at least 6 months from the date of exercise. 

  

	 	21.4	The Company and its Affiliates shall have the right to deduct from all amounts paid to an Optionee in cash (whether under this Plan or otherwise) any taxes required by
law to be withheld in respect of Options under this ESOP. In the case of any Option satisfied by the issuance of Shares, no Shares shall be issued unless and until arrangements satisfactory to the Committee shall have been made to satisfy any
withholding tax obligations applicable with respect to such Option. Without limiting the generality of the foregoing and subject to such terms and conditions as the Committee may impose, the Company and its Affiliates shall have the right to retain,
or the Committee may, subject to such terms and conditions as it may establish from time to time, permit Optionees to elect to tender, Shares to satisfy, in whole or in part, the amount required to be withheld. 

 

	 	21.5	In respect of any employer’s tax liability arising only for the purpose of employment taxes such as in the case of social taxes resulting from a breach of
Section 102, the Company and its Affiliates shall not bear any tax due at the time of sale of Shares, all in accordance with the provisions of Section 102. 

	 	21.6	Notwithstanding anything herein to the contrary of Section 21.5 above, only in the event of termination of employment by the Company, other than termination for
Cause, the Company or its Affiliates should bear the tax liability arising only for the purpose of employment taxes such as in the case of social taxes. 

  

	 	21.7	For avoidance of any doubt, notwithstanding anything herein to the contrary, if termination of employment or service is for Cause, the Company and its Affiliates shall
not bear any tax liability derived due to the exercise and or sale of the Options as a result of Optionee’s termination. 

  

	22.	NON-EXCLUSIVITY OF THIS ESOP 

 The adoption of this ESOP by the Board shall not be construed as amending, modifying or rescinding any previously approved incentive arrangements or as creating any limitations on the power of the Board
to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of options to purchase shares of the Company otherwise than under this ESOP, and such arrangements may be either applicable generally or
only in specific cases. 
 For the avoidance of doubt, prior grant of options to Employees and/or Non-Employees of Traffix or its
Affiliates under their employment agreements or other engagement agreements, and not in the framework of any previous option plan, shall not be deemed an approved incentive arrangement for the purpose of this Section 22. 

 

	23.	MULTIPLE AGREEMENTS 

 The
terms of each Option may differ from the terms of other Options granted under this ESOP at the same time, or at any other time. The Board may also grant more than one Option to a given Optionee during the term of this ESOP, either in addition to, or
in substitution for, one or more Options previously granted to that Optionee. 
  

	24.	DISPUTES 

 Any dispute or
disagreement which may arise under or as a result of or pursuant to this ESOP or the individual Grant Letters shall be determined by the Board in its sole discretion and any interpretation made by the Board of the terms of this ESOP or the
individual Grant Letters shall be final, binding and conclusive. 
 This ESOP was approved by the Board on February 18, 2012, and shall be
effective as of February 21, 2012.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]